MedPath

Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

Not Applicable
Not yet recruiting
Conditions
Parkinson Disease
Interventions
Device: Stanford Glove
Registration Number
NCT06028477
Lead Sponsor
Stanford University
Brief Summary

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and/or deep brain stimulation. Patients will be followed for 14 months.

Detailed Description

The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with Parkinson's disease and inform the investigators on whether unilateral stimulation could be as effective as bilateral stimulation at producing clinically significant improvements in symptoms.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria

Ages 18 or older

  • Diagnosed with idiopathic Parkinson's Disease
  • Fluent in English
  • Off-state UPDRS III motor score at least 30, as assessed within the past 6 months before study consent or at Screening Visit.
  • Demonstrates understanding of the study requirements and is able and willing to sign the informed consent form and complete study procedures.
Exclusion Criteria
  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  • Pregnancy, breast-feeding or wanting to become pregnant
  • Physical limitations unrelated to PD that would affect motor ratings
  • Has implantation of a medical device
  • Sensory abnormalities of the fingertips

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Active stimulationStanford GloveParticipants will receive active stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR
Sham StimulationStanford GloveParticipants will receive sham stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR
Primary Outcome Measures
NameTimeMethod
Change in MDS-Unified Parkinson's Disease Rating Scale Part III Scale ScoreBaseline and month 6

Mean change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III score.

Minimum score - 0 indicates normal functioning Maximum score - 132 indicated severe impairment

Lower scores indicate greater functionality and higher scores indicate severe impairment in functionality.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath